Cargando…

Cell-selective oligonucleotide STAT3 inhibitor for immunotherapy of human acute myeloid leukemia

Detalles Bibliográficos
Autores principales:	Zhang, Qifang, Hossain, Sakib, Moreira, Dayson, Duttagupta, Priyanka, Zhao, Xingli, Swiderski, Piotr, Kortylewski, Marcin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649315/ http://dx.doi.org/10.1186/2051-1426-3-S2-P362

Ejemplares similares

Systemic delivery of TLR9-activating/STAT3-blocking oligonucleotides induces leukemia regression
por: Zhang, Qifang, et al.
Publicado: (2014)

Targeted TLR9-activation/STAT3-blocking abrogates immunosuppressive functions of myeloid-derived suppressor cells from late-stage prostate cancer patients
por: Md Sakib Hossain, Dewan, et al.
Publicado: (2014)

B Cell Lymphoma Immunotherapy Using TLR9-Targeted Oligonucleotide STAT3 Inhibitors
por: Zhao, Xingli, et al.
Publicado: (2018)

The revival of CpG oligonucleotide-based cancer immunotherapies
por: Adamus, Tomasz, et al.
Publicado: (2018)

TLR9 signaling through NF-κB/RELA and STAT3 promotes tumor-propagating potential of prostate cancer cells
por: Moreira, Dayson, et al.
Publicado: (2015)

Use of cellular immunotherapy for treatment of refractory acute myeloid leukemia
por: Fast, Loren, et al.
Publicado: (2013)

Next-generation dendritic cells for immunotherapy of acute myeloid leukemia
por: Schnorfeil, Frauke, et al.
Publicado: (2014)

Glioma-targeted delivery of exosome-encapsulated antisense oligonucleotides using neural stem cells
por: Adamus, Tomasz, et al.
Publicado: (2021)

Reduced T-cell Numbers and Elevated Levels of Immunomodulatory Cytokines in Metastatic Prostate Cancer Patients De Novo Resistant to Abiraterone and/or Enzalutamide Therapy
por: Pal, Sumanta K., et al.
Publicado: (2019)

STAT3 in Tumor-Associated Myeloid Cells: Multitasking to Disrupt Immunity
por: Su, Yu-Lin, et al.
Publicado: (2018)

Recombinant trail: a synergistic effect in myeloid leukemias
por: Carvalho, Filipa, et al.
Publicado: (2010)

Calreticulin mediates immune recognition of acute myeloid leukemia cells in vivo
por: Chen, Xiufen, et al.
Publicado: (2013)

Metformin suppresses pediatric acute myeloid leukemia cell viability and clonogenicity
por: Gopalakrishnapillai, Anilkumar, et al.
Publicado: (2014)

Sunitinib effectively reduces clonogenic acute myeloid leukemia cells in vitro
por: Ahmed, Farid, et al.
Publicado: (2014)

Treatment of transthyretin (TTR) amyloid cardiomyopathy with an antisense oligonucleotide inhibitor of TTR synthesis
por: Benson, Merrill D, et al.
Publicado: (2015)

Prognostically relevant natural killer cell-mediated immunoediting in acute myeloid leukemia
por: Chan, Christopher J, et al.
Publicado: (2013)

Growth after hematopoietic stem cell transplantation in children with acute myeloid leukemia
por: Chung, Seung Joon, et al.
Publicado: (2013)

Optimising oligonucleotide array design for ChIP-on-chip
por: Nielsen, Fiona, et al.
Publicado: (2007)

A novel biomarker assay for cancer immunotherapy development based on myeloid derived supressor cells (MDSCs)
por: Hepburne-Scott, Henry
Publicado: (2013)

A Phase I trial of MGD006 in patients with relapsed acute myeloid leukemia (AML)
por: Uy, Geoffrey, et al.
Publicado: (2014)

Activation of the STING pathway enhances immunity and improves survival in a murine myeloid leukemia model
por: Curran, Emily, et al.
Publicado: (2014)

HIV-associated cellular proteins in human cervicovaginal lavage samples from HIV-negative women
por: Basu, J, et al.
Publicado: (2006)

A single nucleotide polymorphism in Wilms’ tumor 1 gene and the risk of acute myeloid leukemia in Sudan
por: Ahmed, Amr A, et al.
Publicado: (2014)

Comparative genomic hybridization using oligonucleotide arrays and total genomic DNA
por: Barrett, MT, et al.
Publicado: (2005)

Immunotherapy using bispecific T cell engager (BiTE(®)) antibodies: preclinical and clinical experience in acute leukemia
por: Subklewe, Marion, et al.
Publicado: (2014)

Immune suppression by myeloid-derived suppressor cells, MDSCs, in MYCN-driven neuroblastoma provides a potential target for cancer immunotherapy
por: Eissler, Nina, et al.
Publicado: (2014)

Targeting miR-126 in inv(16) acute myeloid leukemia inhibits leukemia development and leukemia stem cell maintenance
por: Zhang, Lianjun, et al.
Publicado: (2021)

Quality control of DNA with on-chip electrophoresis for oligonucleotide-array comparative genomic hybridization
por: Buhlmann, C, et al.
Publicado: (2005)

P507: SALVAGE THERAPY WITH VENETOCLAX IN COMBINATION WITH AZACITIDINE, HOMOHARRINGTONINE AND CYTARABINE IN PATIENTS WITH RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA
por: Yuan, Linyu, et al.
Publicado: (2023)

Frequent microdeletions in conventional papillary thyroid carcinoma detected by high-density oligonucleotide microarrays
por: Al-Ahmadi, Alaa, et al.
Publicado: (2014)

Push and release: TLR9 activation plus STAT3 blockade for systemic antitumor immunity
por: Kortylewski, Marcin, et al.
Publicado: (2014)

Stat1 and phosphorylated Stat1 are increased in lymphocytes and monocytes of patients with systemic lupus erythematosus
por: Aringer, M, et al.
Publicado: (2005)

P317: ANTI-LEUKEMIA ACTIVITY OF CD70-DIRECTED IMMUNOTHERAPY IN B CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA
por: Sun, Qian, et al.
Publicado: (2023)

P437: EFFECTIVE IMMUNOTHERAPY OF PEDIATRIC T(8;21) ACUTE MYELOID LEUKEMIA BY REPURPOSING CD3XCD19 TARGETING BISPECIFIC ANTIBODIES
por: Wijnen, Noa, et al.
Publicado: (2023)

Use of CD200 blockade inhibitor to enhance glioma immunotherapy
por: Mesias, Elisabet, et al.
Publicado: (2015)

Association of Genetic Polymorphisms in STAT 3, STAT 5b and GWAS Identified PTPN22 Gene with Rheumatic Heart Disease
por: Gupta, Usha, et al.
Publicado: (2014)

Indoleamine 2,3-dioxygenase-1 (IDO1) expression by childhood acute myeloid leukemias inhibits T-cell production of IFN-γ and confers an unfavorable prognosis
por: Rutella, Sergio, et al.
Publicado: (2013)

Emerging Immunotherapy for Acute Myeloid Leukemia
por: Tabata, Rikako, et al.
Publicado: (2021)

Development and evaluation of the oligonucleotide ligation assay (OLA) for the detection of drug resistance mutations in HIV-2 patients on antiretroviral therapy
por: Jallow, Sabelle, et al.
Publicado: (2006)

Combined modality radiation therapy promotes tolerogenic myeloid cell populations and STAT3-related gene expression in head and neck cancer patients
por: Sampath, Sagus, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_3h71fnrcq1f0q4dhli9g0jdfra